Elisa García

845 total citations
32 papers, 593 citations indexed

About

Elisa García is a scholar working on Pathology and Forensic Medicine, Cellular and Molecular Neuroscience and Developmental Neuroscience. According to data from OpenAlex, Elisa García has authored 32 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 20 papers in Cellular and Molecular Neuroscience and 7 papers in Developmental Neuroscience. Recurrent topics in Elisa García's work include Spinal Cord Injury Research (27 papers), Nerve injury and regeneration (20 papers) and Neurogenesis and neuroplasticity mechanisms (6 papers). Elisa García is often cited by papers focused on Spinal Cord Injury Research (27 papers), Nerve injury and regeneration (20 papers) and Neurogenesis and neuroplasticity mechanisms (6 papers). Elisa García collaborates with scholars based in Mexico, United States and Spain. Elisa García's co-authors include Antonio Ibarra, Raúl Silva‐García, Susana Martiñón, Humberto Mestre, Sam Milstein, Doris J. Bucher, Ana María Fernández-Presas, Gabriel Gutiérrez‐Ospina, Gabriel Guı́zar-Sahagún and Marı́a G. Campos and has published in prestigious journals such as PLoS ONE, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

Elisa García

31 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa García Mexico 14 357 230 118 113 102 32 593
Oyinbo Charles Aidemise Nigeria 5 418 1.2× 211 0.9× 140 1.2× 76 0.7× 67 0.7× 10 635
Yingchun Han United States 12 341 1.0× 140 0.6× 186 1.6× 56 0.5× 51 0.5× 22 672
Jonathon Chon Teng Chio Canada 9 219 0.6× 164 0.7× 100 0.8× 71 0.6× 52 0.5× 12 378
Zengming Zheng China 14 346 1.0× 102 0.4× 273 2.3× 53 0.5× 60 0.6× 21 746
Isaac Francos-Quijorna Spain 12 230 0.6× 181 0.8× 248 2.1× 82 0.7× 272 2.7× 19 816
Zili He China 14 248 0.7× 112 0.5× 162 1.4× 23 0.2× 109 1.1× 14 569
Martine Lessard Canada 7 288 0.8× 168 0.7× 200 1.7× 50 0.4× 348 3.4× 7 724
James Michael Wingrave United States 9 240 0.7× 182 0.8× 187 1.6× 22 0.2× 62 0.6× 11 556
Francesco Boato Germany 13 160 0.4× 186 0.8× 177 1.5× 29 0.3× 104 1.0× 13 549
Hong Peng China 12 133 0.4× 160 0.7× 181 1.5× 25 0.2× 50 0.5× 26 471

Countries citing papers authored by Elisa García

Since Specialization
Citations

This map shows the geographic impact of Elisa García's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa García with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa García more than expected).

Fields of papers citing papers by Elisa García

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa García. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa García. The network helps show where Elisa García may publish in the future.

Co-authorship network of co-authors of Elisa García

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa García. A scholar is included among the top collaborators of Elisa García based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa García. Elisa García is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
García, Elisa, et al.. (2023). Recent advances in the combination of cellular therapy with stem cells and nanoparticles after a spinal cord injury. Frontiers in Neurology. 14. 1127878–1127878. 12 indexed citations
3.
García, Elisa, et al.. (2023). Use of Cells, Supplements, and Peptides as Therapeutic Strategies for Modulating Inflammation after Spinal Cord Injury: An Update. International Journal of Molecular Sciences. 24(18). 13946–13946. 4 indexed citations
4.
Gutiérrez-Salmeán, Gabriela, et al.. (2022). Memory improvement in senile rats after prebiotic and probiotic supplementation is not induced by GLP‐1. CNS Neuroscience & Therapeutics. 28(12). 1986–1992. 4 indexed citations
5.
García, Elisa, et al.. (2021). Identifying glial scar tissue using infrared thermography: a spinal cord injury pilot study. 1(1). 22–29. 1 indexed citations
6.
García, Elisa, et al.. (2021). Clinical advances in multiple sclerosis and amyotrophic lateral sclerosis treatment: A review. 1(2). 58–69. 3 indexed citations
7.
García, Elisa, Ana María Fernández-Presas, Diego Incontri‐Abraham, et al.. (2020). Immunization with neural‐derived peptides increases neurogenesis in rats with chronic spinal cord injury. CNS Neuroscience & Therapeutics. 26(6). 650–658. 14 indexed citations
8.
Orozco‐Suárez, Sandra, Elisa García, Ismael Jiménez‐Estrada, et al.. (2020). Single vs. Combined Therapeutic Approaches in Rats With Chronic Spinal Cord Injury. Frontiers in Neurology. 11. 136–136. 11 indexed citations
9.
Ibarra, Antonio, et al.. (2020). Neuroprotective effect of immunomodulatory peptides in rats with traumatic spinal cord injury. Neural Regeneration Research. 16(7). 1273–1273. 10 indexed citations
10.
García, Elisa, et al.. (2018). The Severity of Spinal Cord Injury Determines the Inflammatory Gene Expression Pattern after Immunization with Neural-Derived Peptides. Journal of Molecular Neuroscience. 65(2). 190–195. 11 indexed citations
11.
García, Elisa, et al.. (2017). Anterior chamber associated immune deviation used as a neuroprotective strategy in rats with spinal cord injury. PLoS ONE. 12(11). e0188506–e0188506. 9 indexed citations
12.
Fernández-Presas, Ana María, Elisa García, Raúl Silva‐García, et al.. (2017). Immunization with neural derived peptides plus scar removal induces a permissive microenvironment, and improves locomotor recovery after chronic spinal cord injury. BMC Neuroscience. 18(1). 7–7. 20 indexed citations
13.
Ibarra, Antonio, et al.. (2016). Spinal cord injury: potential neuroprotective therapy based on neural-derived peptides. Neural Regeneration Research. 11(11). 1762–1762. 8 indexed citations
15.
Ibarra, Antonio, et al.. (2013). Prophylactic neuroprotection with A91 improves the outcome of spinal cord injured rats. Neuroscience Letters. 554. 59–63. 10 indexed citations
16.
García, Elisa, Raúl Silva‐García, Humberto Mestre, et al.. (2011). Immunization with A91 peptide or copolymer‐1 reduces the production of nitric oxide and inducible nitric oxide synthase gene expression after spinal cord injury. Journal of Neuroscience Research. 90(3). 656–663. 27 indexed citations
17.
Ibarra, Antonio, et al.. (2010). Immunization with neural-derived antigens inhibits lipid peroxidation after spinal cord injury. Neuroscience Letters. 476(2). 62–65. 31 indexed citations
18.
Martiñón, Susana, Elisa García, T. Ortega, et al.. (2007). Vaccination with a neural‐derived peptide plus administration of glutathione improves the performance of paraplegic rats. European Journal of Neuroscience. 26(2). 403–412. 22 indexed citations
19.
Ibarra, Antonio, Susana Martiñón, Elisa García, et al.. (2007). Cyclosporin-A enhances non-functional axonal growing after complete spinal cord transection. Brain Research. 1149. 200–209. 23 indexed citations
20.
Milstein, Sam, et al.. (1993). Oral Immunization of Rats with Proteinoid Microspheres Encapsulating Influenza Virus Antigens. Pharmaceutical Research. 10(8). 1243–1247. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026